CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...

CVS could wind up as the only pharmacy stock in the U.S. if Walgreens goes private. But the drugstore chain, worth about $65 ...

Zydus Lifesciences is attempting to move up the value chain in the global pharma ... Zydus Lifesciences had entered into an agreement with CVS Caremark for launch of medicines in the US market ...

Over nearly two decades, CVS Health Corp. has spent billions of dollars on acquisitions — for pharmacy benefits manager Caremark Rx in ... The drugstore chain’s most recent annual report ...

With Walgreens (NASDAQ:WBA) agreeing to a subpar M&A deal with private equity firm Sycamore Partners, CVS Health (NYSE:CVS) will soon become the only listed brick-and-mortar pharmacy chain ...

“The application is designed to appeal to CVS Caremark members that value the need for a mobile connection with our Web site and services.” CVS Caremark claims to be the largest pharmacy ...

While front-of-the-store sales are anemic in the face of stiff competition, CVS Caremark is experiencing ... that unlock the benefits and value of our integrated model, and mobile is one of ...